Navigation Links
BUSM professor authors book on how knowledge about genes and family history can save lives
Date:8/26/2011

(Boston) World-renowned genetics expert Aubrey Milunsky, MD, DSc, has penned a new book focused on new DNA tests that have dramatically expanded our ability to avoid, prevent, diagnose, predict and treat many genetic disorders. Based on a lifetime of experience, he recounts the lessons learned from many families who benefitted from new advances in genetics, or could have, if they had only known. The book, Your Genes, Your Health: A Critical Family Guide That Could Save Your Life, provides important information about many genetic disorders, more especially since each of us unwittingly carries a significant number of harmful genes.

The National Institutes of Health Office of Rare Diseases reports that there are approximately 7,000 rare genetic disorders that affect about 1 out of every 12 people. In this non-technical comprehensive guide, Milunsky, who is Professor of Human Genetics, Pediatrics, Obstetrics and Gynecology and Pathology at Boston University School of Medicine (BUSM), provides valuable information about many genetic disorders, including cancer, heart disease, autism, mental illness, intellectual disability, birth defects, neurologic disorders, diabetes, obesity and many more. He describes the various options available via genetic counseling for couples at risk of having a child with a genetic disorder, including carrier detection tests, prenatal diagnosis and preimplantation genetic diagnosis.

Milunsky underscores the importance of recognizing seemingly unrelated disorders in a family due to the same genetic mutation to illustrate the vital importance of understanding one's family history and ethnic origin. He also describes the most current tests that can diagnose or predict genetic disorders or that can detect carriers of many different harmful genes.

"Remarkable advances in genetic testing, coupled with people recognizing genetic and familial risk factors, frequently enable avoidance or prevention of serious or lethal genetic disorders and even important treatment," said Milunsky. "By knowing your genes, you may save your life and the lives of those you love."

Milunsky's research accomplishments include leading the research team responsible for first locating the gene for X-linked lymphoproliferative disease and cloning the PAX 3 gene for Waardenburg syndrome. As principal investigator, he also led a team that was the first to demonstrate that 70 percent of spina bifida cases could be avoided by folic acid supplementation taken 3 months prior to pregnancy and 3 months after conception.

Milunsky joined the Boston University community in 1982 when he was named Founding Director of the Center for Human Genetics and appointed Professor of Pediatrics and Obstetrics and Gynecology, both at BUSM. He became a Professor of Pathology in 1985, and in 1991 became the first Endowed Chair in Human Genetics at BUSM, which will be named for him upon his retirement. He has been honored by election as a Fellow of the Royal College of Physicians of England and as a member of the Society for Pediatric Research and the American Pediatrics Society. He is also a Founding Fellow of the American College of Medical Genetics.

In addition to his academic and research successes, Milunsky is the author or co-author of more than 400 scientific communications and author, editor or co-editor of 24 books.

Your Genes, Your Health: A Critical Family Guide That Could Save Your Life, was published by Oxford University Press and is available now to the public.


'/>"/>

Contact: Jenny Eriksen Leary
jenny.eriksen@bmc.org
617-638-6841
Boston University Medical Center
Source:Eurekalert

Related biology news :

1. BUSM professor awarded $13.3 million to study potential treatments to prevent STDs
2. FASEB MARC program announces the travel award recipients for the 2011 Leadership Development and Grant Writing Seminar for graduate students, postdoctoral fellows and new assistant professors
3. MSU professor launches new field of water research, nets $2.2 million NSF grant
4. Trauma drama: K-State professor researches drama queen of immune system
5. Acclaimed chemistry professor wins 2 major awards
6. University of Houston professor co-authors PNAS paper on how bacteria move
7. BUSM professor selected as American Heart Association Distinguished Scientist
8. CWRU law professor eyes prize-based incentives to generate climate innovation
9. Sugar-based chemicals book chapter by NJIT professor takes ACS kudos
10. University of Texas at Austin professor receives Donald L. Katz Award
11. CSHL professor Rob Martienssen receives prestigious appointment as HHMI-GBMF investigator
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2016)... --  EyeLock LLC , a market leader of iris-based ... IoT Center of Excellence in Austin, Texas ... embedded iris biometric applications. EyeLock,s iris authentication ... with unmatched biometric accuracy, making it the most proven ... platform uses video technology to deliver a fast and ...
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted to ... of 2015 The gross margin was 49% (27) ... operating margin was 40% (-13) Earnings per share rose ... was SEK 249.9 M (21.2) , Outlook   ... The operating margin for 2016 is estimated to exceed ...
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... 2016 , ... While the majority of commercial spectrophotometers and fluorometers use the ... models are higher end machines that use the more unconventional z-dimension of 20mm. ... the bottom of the cuvette holder. , FireflySci has developed several Agilent flow ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
Breaking Biology Technology: